Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
Nutrients · 12.01.2023 · 15 (2) · 385
DOI: 10.3390/nu15020385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 12.01.2023. Verfasst von Shilu Deepa Thomas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United …. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: uae university 12R104, 12R121, United Arab Emirates University.
Abstract (Originalsprache)
Apigenin is a naturally occurring dietary flavonoid found abundantly in fruits and vegetables. It possesses a wide range of biological properties that exert antioxidant, anti-inflammatory, anticancer, and antibacterial effects. These effects have been reported to be beneficial in the treatment of atherosclerosis, stroke, hypertension, ischemia/reperfusion-induced myocardial injury, and diabetic cardiomyopathy, and provide protection against drug-induced cardiotoxicity. These potential therapeutic effects advocate the exploration of the cardioprotective actions of apigenin. This review focuses on apigenin, and the possible pharmacological mechanisms involved in the protection against cardiovascular diseases. We further discuss its therapeutic uses and highlight its potential applications in the treatment of various cardiovascular disorders. Apigenin displays encouraging results, which may have implications in the development of novel strategies for the treatment of cardiovascular diseases. With the commercial availability of apigenin as a dietary supplement, the outcomes of preclinical studies may provide the investigational basis for future translational strategies evaluating the potential of apigenin in the treatment of cardiovascular disorders. Further preclinical and clinical investigations are required to characterize the safety and efficacy of apigenin and establish it as a nutraceutical as well as a therapeutic agent to be used alone or as an adjuvant with current drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
- Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201310, Uttar Pradesh, India.
- Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun 248007, Uttarakhand, India.
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
- Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali 140413, Punjab, India.
- Zayed Bin Sultan Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
ORCID-Profile: Shilu Deepa Thomas, Niraj Kumar Jha, Bassem Sadek, Shreesh Ojha
Förderung
- uae university 12R104, 12R121
- United Arab Emirates University
Zitieren
APA
Thomas, S. D., Jha, N. K., Jha, S. K., Sadek, B., & Ojha, S. (2023). Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin. Nutrients, 15(2), 385. https://doi.org/10.3390/nu15020385
Vancouver
Thomas SD, Jha NK, Jha SK, Sadek B, Ojha S. Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin. Nutrients. 2023;15(2):385. doi:10.3390/nu15020385
BibTeX
@article{Thomas2023,
author = {Thomas, Shilu Deepa and Jha, Niraj Kumar and Jha, Saurabh Kumar and Sadek, Bassem and Ojha, Shreesh},
title = {Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {2},
pages = {385},
doi = {10.3390/nu15020385}
}
EUVIMED